Complementary function of the two catalytic domains of APOBEC3G.
about
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesModel structure of human APOBEC3GDeaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminaseThe dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3GHIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodiesAPOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsTargeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityThe localization of APOBEC3H variants in HIV-1 virions determines their antiviral activityStructural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3GHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHuman LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activityAn extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme modelHIV-1 Vif, APOBEC, and intrinsic immunityStructure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3GHuman cytidine deaminase APOBEC3H restricts HIV-1 replicationPolymorphisms and splice variants influence the antiretroviral activity of human APOBEC3HHuman APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GHuman immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integrationAPOBEC3G targets human T-cell leukemia virus type 1.APOBEC3G & HTLV-1: inhibition without deaminationMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allSuppression of APOBEC3-mediated restriction of HIV-1 by VifNMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificityReversed functional organization of mouse and human APOBEC3 cytidine deaminase domainsNewly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase HRNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsA DNA sequence recognition loop on APOBEC3A controls substrate specificityDifferent mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanismsAPOBEC3G: an intracellular centurionHIV/AIDS epidemiology, pathogenesis, prevention, and treatmentMultiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.Nanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA.AID and Apobec3G haphazard deamination and mutational diversity
P2860
Q21090536-91479389-B81F-4B62-BC14-1CE928505D9EQ21092257-4BB61825-C061-411C-9D0C-EAA51F8FD499Q21131577-302058F0-7960-41CE-A252-8D3353B58953Q21245195-3BABD747-76C3-4DF6-9C61-55D32DA7F164Q24297395-C65329CB-6328-4D80-95AF-9336C0DF8D5FQ24310242-78A9693E-DE0E-4996-83A9-7128E9E85A63Q24537623-3A5F4BA2-591E-4345-B5C2-5EF3E45FB725Q24565021-F89F40EF-8A98-4EF0-BC10-C269AD13300FQ24596322-1A471B64-88B4-468F-9950-9874BF3626FDQ24615413-A52AA4CF-8A0A-4570-94F3-1681EB5CA9A6Q24619114-8C9E9E76-F4E5-40AE-A8B8-2D249626DCFDQ24625056-E508F4A9-9186-449C-80F5-7DCFFE9E43D2Q24642268-CCC939CD-BA46-4F1E-85C9-CA4AEF3F2984Q24647833-EE63542A-F9AA-4236-9426-73D5BC16F1DDQ24649945-B26D65CC-206A-477D-A171-42AB45C90BCEQ24653682-086AFB20-7130-4638-92CD-64913E672555Q24655418-C103B7CB-9603-44D2-9EED-DDAF2FCE5DD5Q24655541-0F041C84-B978-4448-93D2-713002A1B2F6Q24669993-78EF9AD7-2293-4583-AE95-99A5FCD1EF44Q24670173-142E5E7C-5B67-4DDD-AB7F-08979CE22866Q24672209-3B36BB25-95C6-4BAF-8047-14DE7BA792F7Q24681427-DE0C9B49-F72B-4E96-9002-7019E708562CQ24684279-99A713A9-9F8A-4771-92E6-15D2616E98F1Q24811566-6BC1CA5D-03B0-435C-80FF-B88F476FF19DQ24811603-5B0A85E6-BFBF-4071-9C99-268CC9A52718Q26823568-A29B637F-EC77-4132-8F9E-1DB86FB52B67Q27025150-A79855BC-2941-4664-98FD-DF140A33D380Q27678249-D131F1B5-3B3E-45BF-815D-18DBEE64EB7AQ28266980-37D8ACC5-CF2D-46F3-955C-978566408B70Q28469134-A3DCEB38-F05D-46C3-8EA2-205923C40337Q28474904-42965EE9-0359-4D60-BD17-60816945331AQ28482052-E5BB9306-40C3-4E79-850B-97F5138768A9Q28538801-163DF643-F506-451B-93B9-D245D7E7470FQ28541264-D127374D-C6E4-4C45-8AF6-6D9886C6591AQ28754989-02B15545-3864-40B5-9DB7-8689E05224CCQ30356074-2C81061F-4231-405B-BCF4-29384184C486Q30381745-266B6DA5-3FB9-4A7A-A3D7-DC3E0D366ADDQ30445599-C1F47C6C-0909-4D42-9840-A1B84E28C37EQ30525163-30270652-1154-4314-9CF9-C9F7A94981EDQ30537745-04C32AC5-DF52-49BA-A161-9574579F606F
P2860
Complementary function of the two catalytic domains of APOBEC3G.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Complementary function of the two catalytic domains of APOBEC3G.
@en
Complementary function of the two catalytic domains of APOBEC3G.
@nl
type
label
Complementary function of the two catalytic domains of APOBEC3G.
@en
Complementary function of the two catalytic domains of APOBEC3G.
@nl
prefLabel
Complementary function of the two catalytic domains of APOBEC3G.
@en
Complementary function of the two catalytic domains of APOBEC3G.
@nl
P2093
P1433
P1476
Complementary function of the two catalytic domains of APOBEC3G.
@en
P2093
Brooke Bollman
Francisco Navarro
Kristopher Chiles
Nathaniel R Landau
Renate König
P304
P356
10.1016/J.VIROL.2005.01.011
P407
P577
2005-03-01T00:00:00Z